Lack of synergism between dazoxiben and dipyridamole following administration to man.
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000328:Adult; D004176:Dipyridamole / Q000494:pharmacology*; D004357:Drug Synergism; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D008297:Male; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D010974:Platelet Aggregation / Q000187:drug effects; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
D007093:Imidazoles; C029166:dazoxiben; D015121:6-Ketoprostaglandin F1 alpha; D004176:Dipyridamole; D010088:Oxidoreductases; D013930:Thromboxane-A Synthase